Genomic Vision develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases
Genomic Vision develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. The company uses Molecular Combing Technology for the direct visualization of single DNA molecules to detect changes in the genome landscape and establish their contribution to pathology.